Skip to content

Management of Hypertension through Ayurveda

Randomized clinical study to evaluate the efficacy of Shuddh Shilajit and Maansyadi Kashaya in the management of Aavrit Vyan w.s.r. to Essential Hypertension

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052301
Enrollment
60
Registered
2023-05-04
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject willing to participate and able to provide written informed consent. 2. Patient diagnosed as stage-I Essential Hypertension would be selected for study on the basis of 8th JNC & WHO criteria. 3. Subjects who are able to come for follow up on fixed visits.

Exclusion criteria

Exclusion criteria: 1. Already diagnosed cases of Cardiovascular disease/ Cerebrovascular disease/ Renal disease/ Hypertensive Retinopathy. 2. Subjects with any unstable heart disease or known cases of MI, unstable angina or CHF. 3. Patients with concurrent hepatic dysfunction (defined as AST and/or ALT >2times of the upper normal limit) or Renal dysfunction, uncontrolled pulmonary dysfunction (asthmatic and COPD subjects). 4. Subjects with current or past malignancy. 5. Subject of have recent history or who are currently known to abuse of alcohol or drugs. 6. Subjects suffering from major systemic illness neccessitating long term drug treatment(rheumatoid arthritis, psyco-neuro-endocrinal disorders, Tb, AIDS). 7. Pregnant/lactating women. 8. Subject on systemic or local steroids, oral contraceptive pills or estrogen replacement therapy. 9. Subjects having hypersensitivity to any of the trial drug. 10. Subjects who have completed participation in any other clinical trial during the past six (06) months.

Design outcomes

Primary

MeasureTime frame
Improvement in Subjective symptomsTimepoint: Follow up at 15 days interval

Secondary

MeasureTime frame
Changes in Blood Pressure readingsTimepoint: Follow up at 15 days interval

Countries

India

Contacts

Public ContactDr Sujata Yadav

Ayurvedic and Unani Tibbia College and Hospital

sujatakcdelhi@gmail.com9354925030

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026